| Barton Gold Holdings Limited (BGD) ORDINARY FULLY PAID |
Materials |
$207 |
Application for quotation of securities - BGD
|
3 Apr 2025 8:57AM |
$0.400 |
$0.865 |
risen by
116.25%
|
|
| Aspire Mining Limited (AKM) ORDINARY FULLY PAID |
Materials |
$119 |
Aspire Enters MoU on Trailer Design, Supply and Maintenance
|
3 Apr 2025 8:56AM |
$0.290 |
$0.235 |
fallen by
18.97%
|
|
| Navigator Global Investments Limited (NGI) FPO-U.S. INVESTOR PROHIBITED EXCEPT QPS |
Financials |
$1,041 |
Goldman Sachs Emerging Leaders Conference Presentation
|
3 Apr 2025 8:56AM |
$1.870 |
$2.120 |
risen by
13.37%
|
|
| Newmont Corporation (NEM) CDI 1:1 FOREIGN EXEMPT NYSE |
Materials |
$159,178 |
Statement of CDIs on issue - NEM
|
3 Apr 2025 8:56AM |
$76.310 |
$146.300 |
risen by
91.72%
|
|
| xReality Group Ltd (XRG) ORDINARY FULLY PAID |
Consumer Discretionary |
$41 |
Strategic law enforcement research program
|
3 Apr 2025 8:55AM |
$0.034 |
$0.054 |
risen by
58.82%
|
|
XRG - Price-sensitive ASX Announcement
Full Release
Key Points
- Strategic research program established with ALERRT Centre at Texas State University.
- Focus on enhancing active shooter response training using XR technology.
- Initial two-year collaboration with potential for renewal based on mutual agreement.
- Research will optimize Operator XR's technology platform in high-stress law enforcement scenarios.
- ALERRT has trained over 300,000 first responders in the US.
- The collaboration aims to improve human performance in high-stress situations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| L1 Long Short Fund Limited (LSF) ORDINARY FULLY PAID |
Financials |
$2,491 |
Change of Director's Interest Notice - RL
|
3 Apr 2025 8:54AM |
$2.860 |
$3.930 |
risen by
37.41%
|
|
| L1 Long Short Fund Limited (LSF) ORDINARY FULLY PAID |
Financials |
$2,491 |
Change of Director's Interest Notice - ML
|
3 Apr 2025 8:54AM |
$2.860 |
$3.930 |
risen by
37.41%
|
|
| Resimac Group Limited (RMC) ORDINARY FULLY PAID |
Financials |
$368 |
Update - Notification of buy-back - RMC
|
3 Apr 2025 8:51AM |
$0.855 |
$0.930 |
risen by
8.77%
|
|
| Summerset Group Holdings Limited (SNZ) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Health Care |
$1,858 |
Ongoing Disclosure Notices
|
3 Apr 2025 8:51AM |
$10.190 |
$7.660 |
fallen by
24.83%
|
|
| EROAD Limited (ERD) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Information Technology |
$136 |
Ongoing Disclosure Notice - John Scott
|
3 Apr 2025 8:51AM |
$0.850 |
$0.725 |
fallen by
14.71%
|
|
| Imugene Limited (IMU) ORDINARY FULLY PAID |
Health Care |
$51 |
1st dose level cleared IV combination arm onCARlytics trial
|
3 Apr 2025 8:51AM |
$0.030 |
$0.143 |
risen by
375%
|
|
| Argent Biopharma Limited (RGT) ORDINARY FULLY PAID |
Health Care |
$4 |
CannEpil Receives Approval for Prescription in Germany
|
3 Apr 2025 8:49AM |
$0.130 |
$0.040 |
fallen by
69.23%
|
|
RGT - Price-sensitive ASX Announcement
Full Release
Key Points
- CannEpilâ„¢ has been approved for prescription in Germany.
- This approval expands Argent BioPharma's presence in the European market.
- Physicians can now prescribe CannEpilâ„¢, allowing eligible patients access.
- Approximately 816,000 people in Germany are diagnosed with epilepsy.
- CannEpilâ„¢ offers a vital alternative for patients with limited treatment options.
- The approval represents a significant step in the company's European expansion strategy.
- Argent BioPharma aims to provide innovative treatments for CNS disorders.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tasmea Limited (TEA) ORDINARY FULLY PAID |
Industrials |
$1,277 |
Acquisition of Flanco Group - Presentation
|
3 Apr 2025 8:48AM |
$2.550 |
$4.905 |
risen by
92.35%
|
|
TEA - Price-sensitive ASX Announcement
Full Release
Key Points
- Acquisition estimated at approximately A$27 million.
- Flanco Group specializes in civil services and maintenance solutions.
- Transaction expected to enhance Tasmea's operational footprint in the Goldfields region.
- Deal projected to be earnings accretive, enhancing shareholder value.
- Expected completion of the transaction by early May 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tasmea Limited (TEA) ORDINARY FULLY PAID |
Industrials |
$1,277 |
Acquisition of Flanco Group - Announcement
|
3 Apr 2025 8:47AM |
$2.550 |
$4.905 |
risen by
92.35%
|
|
TEA - Price-sensitive ASX Announcement
Full Release
Key Points
- Tasmea to acquire Flanco Pty Ltd and Flanco Kalgoorlie Pty Ltd.
- Completion of the acquisition expected in early May 2025.
- Flanco Group specializes in civil services and maintenance solutions.
- Flanco Group has achieved strong revenue growth with a CAGR of approximately 23%.
- The acquisition enhances Tasmea's operational capabilities.
- Total consideration of around A$50 million.
- Deal includes upfront cash payment and potential earn-out based on performance.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Evolution Mining Limited (EVN) ORDINARY FULLY PAID |
Materials |
$26,012 |
Mungari Expansion Project Commences Commissioning
|
3 Apr 2025 8:46AM |
$7.110 |
$12.810 |
risen by
80.17%
|
|
| Perpetual Credit Income Trust (PCI) ORDINARY UNITS FULLY PAID |
Financials |
$764 |
Update - Dividend/Distribution - PCI
|
3 Apr 2025 8:43AM |
$1.180 |
$1.045 |
fallen by
11.44%
|
|
| Tower Limited (TWR) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Financials |
$536 |
Disclosure of ceasing to have substantial holding
|
3 Apr 2025 8:43AM |
$1.265 |
$1.560 |
risen by
23.32%
|
|
| Percheron Therapeutics Limited (PER) ORDINARY FULLY PAID |
Health Care |
$5 |
Change of Director's Interest Notice - Dr Ben Gil Price
|
3 Apr 2025 8:41AM |
$0.010 |
$0.005 |
fallen by
50%
|
|
| Clearview Wealth Limited (CVW) ORDINARY FULLY PAID |
Financials |
$397 |
Update - Notification of buy-back - CVW
|
3 Apr 2025 8:40AM |
$0.460 |
$0.633 |
risen by
37.50%
|
|
| Treasury Wine Estates Limited (TWE) ORDINARY FULLY PAID |
Consumer Staple |
$2,782 |
Minimal impact expected from US tariffs on Aus and NZ wine
|
3 Apr 2025 8:38AM |
$9.100 |
$3.445 |
fallen by
62.14%
|
|
| Artemis Resources Limited (ARV) ORDINARY FULLY PAID |
Materials |
$21 |
GRE: Greentech and Artemis Consolidate Lithium Rights
|
3 Apr 2025 8:37AM |
$0.009 |
$0.006 |
fallen by
38.89%
|
|
ARV - Price-sensitive ASX Announcement
Full Release
Key Points
- GreenTech and Artemis have consolidated lithium mineral rights.
- The joint venture is named Andover Lithium Pty Ltd.
- Each company owns 50% of Andover Lithium.
- The exploration package spans over 420 km² in the West Pilbara region.
- The combined tenements include undrilled outcrops of lithium-bearing pegmatite.
- The consolidation aims to attract major funding partners.
- GreenTech focuses on copper and zinc, while Artemis focuses on gold.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| GreenTech Metals Limited (GRE) ORDINARY FULLY PAID |
Materials |
$19 |
Greentech and Artemis Consolidate Lithium Rights
|
3 Apr 2025 8:37AM |
$0.076 |
$0.071 |
fallen by
6.58%
|
|
GRE - Price-sensitive ASX Announcement
Full Release
Key Points
- GreenTech Metals Limited and Artemis Resources consolidate lithium mineral rights.
- Joint venture named Andover Lithium Pty Ltd created.
- Over 420 km² lithium exploration package established.
- Each company owns 50% of Andover Lithium.
- Strategic move to attract funding partners.
- Consolidation allows focus on core resource expansion activities.
- No substantial management time or costs expected from the agreement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Hexima Limited (HXL) ORDINARY FULLY PAID |
Health Care |
$2 |
Notification of cessation of securities - HXL
|
3 Apr 2025 8:37AM |
$0.013 |
$0.013 |
fallen by
0%
|
|
| Fisher & Paykel Healthcare Corporation Limited (FPH) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Health Care |
$18,399 |
New US tariffs announced today
|
3 Apr 2025 8:37AM |
$31.480 |
$31.330 |
fallen by
0.48%
|
|
FPH - Price-sensitive ASX Announcement
Full Release
Key Points
- US announced new tariffs including 10% on products from New Zealand.
- Fisher & Paykel Healthcare manufactures 45% of its products in Mexico and 55% in New Zealand.
- 43% of the company's revenue for the first half of the 2025 financial year came from the US.
- 60% of US volumes supplied from Mexico; 40% from New Zealand.
- Company expects no material impact on net profit for the 2025 financial year.
- Costs likely to increase in the 2026 financial year due to new tariffs.
- Company aims to achieve gross margin targets through continuous improvement activities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| NobleOak Life Limited (NOL) ORDINARY FULLY PAID |
Financials |
$117 |
Victorian stamp duty reforms
|
3 Apr 2025 8:36AM |
$1.510 |
$1.260 |
fallen by
16.56%
|
|
NOL - Price-sensitive ASX Announcement
Full Release
Key Points
- NobleOak Life Limited is evaluating the implications of stamp duty changes in Victoria.
- Recent amendments to the Victorian Duties Act 2000 affect stamp duty exemptions for friendly societies.
- Stamp duty obligations will apply to specific insurance contracts from January 2025.
- NobleOak is engaging with the State Revenue Office to clarify the application of these reforms.
- Stamp duty on insurance contracts in Victoria is set at 10% of the premium.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.